{"company":{"id":3792624,"name":"NUVATION BIO","domain":"nuvationbio.com","url":"https://alion.io/company/nuvationbio"},"section":"news","answer":"NUVATION BIO: 22 headlines on record, 4 headlines in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"22"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":1},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"date":"2026-10-10","kind":"Press release","title":"Nuvation Bio (NUVB) Receives a Buy from RBC Capital","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/stocks/NUVB/pressreleases/5521406/nuvation-bio-nuvb-receives-a-buy-from-rbc-capital/"}],"story":[{"title":"Certified Nuvation Bio Announces Fda Approval of Supplemental New Drug Application for Ibtrozi (Taletrectinib) with Updated Duration of Response in Tki-Naive A… · marketscreener.com","url":"https://marketscreener.com/news/nuvation-bio-announces-fda-approval-of-supplemental-new-drug-application-for-ibtrozi-taletrectinib-ce785bd3dd8ff027"},{"title":"Team of 215 was 144 · US Form 5500 (plan participants)"},{"title":"Raised a round Venture round $275.3M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1829093/000173907420000013/"},{"title":"Founded"}],"as_of":"2026-11-20","cite":"NUVATION BIO, News. Alion, Nov 20, 2026. https://alion.io/company/nuvationbio/news","html_url":"https://alion.io/company/nuvationbio/news","json_url":"https://alion.io/company/nuvationbio/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-20T20:44:37Z"}}